| __timestamp | Amicus Therapeutics, Inc. | ImmunityBio, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 47624000 | 1595000 |
| Thursday, January 1, 2015 | 76943000 | 11434000 |
| Friday, January 1, 2016 | 104793000 | 26546000 |
| Sunday, January 1, 2017 | 149310000 | 39778000 |
| Monday, January 1, 2018 | 270902000 | 53418000 |
| Tuesday, January 1, 2019 | 286378000 | 111997000 |
| Wednesday, January 1, 2020 | 308443000 | 139507000 |
| Friday, January 1, 2021 | 272049000 | 195958000 |
| Saturday, January 1, 2022 | 276677000 | 248149000 |
| Sunday, January 1, 2023 | 152381000 | 232366000 |
Unleashing the power of data
In the competitive landscape of biotechnology, strategic investment in research and development (R&D) is crucial for innovation and growth. Over the past decade, Amicus Therapeutics and ImmunityBio have demonstrated distinct approaches to R&D spending. From 2014 to 2023, Amicus Therapeutics consistently increased its R&D expenses, peaking in 2020 with a 547% increase from 2014. However, a notable decline occurred in 2023, with spending dropping by nearly 45% from its 2020 high. In contrast, ImmunityBio's R&D investment surged dramatically, especially from 2018 onwards, culminating in a 2023 expenditure that was 145 times its 2014 level. This strategic focus highlights ImmunityBio's aggressive push towards innovation. As these companies navigate the evolving biotech landscape, their R&D strategies will likely play a pivotal role in their future success.
Who Prioritizes Innovation? R&D Spending Compared for Takeda Pharmaceutical Company Limited and ImmunityBio, Inc.
Research and Development Investment: Alnylam Pharmaceuticals, Inc. vs Amicus Therapeutics, Inc.
Research and Development Investment: Pharming Group N.V. vs Amicus Therapeutics, Inc.
Research and Development Investment: Alpine Immune Sciences, Inc. vs ImmunityBio, Inc.
R&D Insights: How Verona Pharma plc and Amicus Therapeutics, Inc. Allocate Funds
Research and Development Expenses Breakdown: ADMA Biologics, Inc. vs Amicus Therapeutics, Inc.
R&D Spending Showdown: CymaBay Therapeutics, Inc. vs ImmunityBio, Inc.
Comparing Innovation Spending: Xenon Pharmaceuticals Inc. and ImmunityBio, Inc.
R&D Spending Showdown: ACADIA Pharmaceuticals Inc. vs Amicus Therapeutics, Inc.
R&D Spending Showdown: Amicus Therapeutics, Inc. vs Iovance Biotherapeutics, Inc.
Research and Development Investment: Amicus Therapeutics, Inc. vs Viridian Therapeutics, Inc.
Analyzing R&D Budgets: ImmunityBio, Inc. vs Travere Therapeutics, Inc.